NASDAQ: PMN - ProMIS Neurosciences, Inc.

Lønnsomhet i seks måneder: -45.78%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan ProMIS Neurosciences, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet ProMIS Neurosciences, Inc.

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a TDP-43; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils.

flere detaljer
The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2007-07-17
ISIN CA74346M4065
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.promisneurosciences.com
Цена ао 1.94
Prisendring per dag: -3.23% (0.93)
Prisendring per uke: -2.17% (0.92)
Prisendring per måned: -4.26% (0.94)
Prisendring over 3 måneder: -29.69% (1.28)
Prisendring over seks måneder: -45.78% (1.66)
Prisendring per år: -21.74% (1.15)
Prisendring over 3 år: +800% (0.1)
Prisendring over 5 år: +542.86% (0.14)
Prisendring over 10 år: 0% (0.9)
Prisendring siden begynnelsen av året: -2.17% (0.92)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 0 0
P/BV 2.24 7
P/E 0 0
EV/EBITDA 0.2826 10
Total: 4.63

Effektivitet

Navn Betydning Karakter
ROA, % -73.22 0
ROE, % -265.68 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA 0 10
Total: 9.6

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 0 0
Lønnsomhet Ebitda, % 212.45 10
Lønnsomhet EPS, % 8.71 2
Total: 6.4
Flere detaljer

Institusjoner Volum Dele, %
Sphera Funds Management Ltd. 1834042 9.67
Ally Bridge Group (NY) LLC 1066674 5.63
Affinity Asset Advisors, LLC 265958 1.4
Northeast Financial Consultants Inc 100000 0.53
IEQ CAPITAL, LLC 30799 0.16
Fiduciary Trust Company (MA) 20008 0.11
Kingsview Wealth Management, LLC 11100 0.06
Claret Asset Management Corp 10830 0.06
UBS Group AG 5926 0.03
Bank of America Corporation 1666 0.01



Veileder Stillingstittel Betaling Fødselsår
Dr. Neil R. Cashman M.D. Co-Founder, Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Director 333.8k 1952 (73 år)
Mr. Gavin T. Malenfant Chief Operating Officer 413.49k 1964 (61 år)
Mr. Daniel E. Geffken M.B.A. Chief Financial Officer 89.99k 1957 (68 år)
Dr. Johanne Kaplan Ph.D. Chief Development Officer 263.07k 1960 (65 år)
Dr. Ernest D. Bush Ph.D. Head of Pharmacology/Toxicology & Senior Consultant N/A
Dr. David Wishart Ph.D. Chief Physics Officer N/A
Mr. Dennis Chen Ph.D. Head of Manufacturing & Senior Consultant N/A
Dr. Larry Douglas Altstiel M.D., Ph.D. Chief Medical Officer N/A 1950 (75 år)
Mr. Neil K. Warma M.B.A. President, Interim CEO & Director 40k 1963 (62 år)
Mr. Eugene W. Williams Co-Founder & Chairman 1959 (66 år)

Adresse: Canada, Toronto. ON MS E, 1920 Yonge Street - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.promisneurosciences.com